TY - JOUR
T1 - Parkinson's Disease and Nonpharmacologic Treatment Programs
AU - Weiner, William J.
AU - Singer, Carlos
PY - 1989/4
Y1 - 1989/4
N2 - Although objective studies to confirm the role of physical therapy, occupational therapy, and speech therapy in the patient with Parkinson's disease are scarce, each of these therapy modalities can play a certain role in the management of the appropriate patient. In the mildly affected patient, there is little need for any of these interventions; however, as the disease progresses, pharmacologic treatment is usually not totally effective in controlling the signs and symptoms and all of these nonpharmacologic therapy moalities may eventually be utilized. Physical therapy alone cannot effectively treat Parkinson's disease and its long-term effects on patient performance is limited. However, patients and their families often report subjective improvement when physical therapy is used, and these reports cannot be discounted. Improvement with pharmacologic treatment, while more easily assessed objectively, is also not long-lasting. So long as Parkinson's disease remains a progressive disorder, all treatment modalities must be evaluated in the context of a progressively worsening neurologic picture.
AB - Although objective studies to confirm the role of physical therapy, occupational therapy, and speech therapy in the patient with Parkinson's disease are scarce, each of these therapy modalities can play a certain role in the management of the appropriate patient. In the mildly affected patient, there is little need for any of these interventions; however, as the disease progresses, pharmacologic treatment is usually not totally effective in controlling the signs and symptoms and all of these nonpharmacologic therapy moalities may eventually be utilized. Physical therapy alone cannot effectively treat Parkinson's disease and its long-term effects on patient performance is limited. However, patients and their families often report subjective improvement when physical therapy is used, and these reports cannot be discounted. Improvement with pharmacologic treatment, while more easily assessed objectively, is also not long-lasting. So long as Parkinson's disease remains a progressive disorder, all treatment modalities must be evaluated in the context of a progressively worsening neurologic picture.
UR - http://www.scopus.com/inward/record.url?scp=0024520645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024520645&partnerID=8YFLogxK
U2 - 10.1111/j.1532-5415.1989.tb05505.x
DO - 10.1111/j.1532-5415.1989.tb05505.x
M3 - Article
C2 - 2646351
AN - SCOPUS:0024520645
VL - 37
SP - 359
EP - 363
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
SN - 0002-8614
IS - 4
ER -